The Healthtech Podcast

For this week's Sunday Session, James looks back on his first year as a doctor and gives a few tips and anecdotes for those looking to innovate, be that through QI projects, as an interpreneur or as an entrepreneur. Whether you're fixing a printer or overhaul an entire system, there is no project too big or too small to either learn from or make impact with. Empathy and understanding of how everyone in the hospital works is crucial and James talks about the value of spending time shadowing and learning from the management side of the hospital to help you make impact. Get in touch: www.jamessomauroo.com | www.somx.co.uk

Robyn Symon is a two-time Emmy award-winning former PBS producer  specializing in documentaries and television series. A former TV news reporter, Robyn has written and produced hundreds of hours of television programming for various networks including PBS, NBC, Discovery, CNBC, HGTV Reelz Channel including the PBS series "Voices of Vision," hosted by NPR's Scott Simon focusing on the work of non-profit organizations around the world and “Florida!" for The Travel Channel.  Recently Robyn produced and directed five television specials for the Reelz Channel on Michael Jackson, Robin Williams and the opioid epedimic in Hollywood (“Fatal Addiction”).  In addition to two Suncoast Emmys, Robyn has been honored with three national Telly awards among others. Her latest film, Do No Harm premiered at the Cleveland International Film Festival: Jumping off hospital rooftops, hanging themselves in janitorial closets, overdosing on drugs—they’re A students and their suicides are often like well-planned school projects. Doctors are our healers, yet they have the highest rate of suicide among any profession. Medical students and families of physicians touched by suicide come out of the shadows to expose this silent epidemic and the truth about a sick healthcare system that not only drives our brilliant young doctors to take their own lives but puts patients lives at risk too. https://www.donoharmfilm.com/ Get in touch: www.jamessomauroo.com | www.somx.co.uk

It's a 241 on GE healthcare this week - Rob Walton, President and CEO across 13 markets is back to give us his top tips for healthtech entrepreneurs. James also talks about perfection being the enemy of progress and how he's had to combat it in the last week!  https://www.linkedin.com/in/rob-walton-511555/ | https://www.gehealthcare.co.uk/ Get in touch: www.jamessomauroo.com | www.somx.co.uk

This week, James is joined by Rob Walton, the president and CEO of GE Healthcare's businesses in 13 markets across Southeast Asia, Korea, Australia and New Zealand. He took on the role in June 2019 and is responsible for leading all the business activities for GE healthcare in the region. https://www.linkedin.com/in/rob-walton-511555/ | https://www.gehealthcare.co.uk/ Get in touch:  www.jamessomauroo.com | www.somx.co.uk

Tomer is a Partner & CFO at aMoon, where he leads mid-late stage investments in healthtech companies. Tomer joined aMoon in early 2018 and led several investments including $30M Series C round in Zebra Medical Vision and $55M Series D round in Seer. He is also a board member in PharmaTwoB and Mapi. With 15 years of US capital markets experience, Tomer spearheads aMoon’s Bridge to Wall Street, where he manages the fund’s relationships with major investment banks, equity research analysts and investment funds. Prior to joining aMoon, Tomer was the CFO & COO of Alcobra, a NASDAQ-listed development-stage biotech company, where he led successful public equity offerings from leading US healthcare funds. Prior to joining Alcobra, he was an Executive Director in J.P. Morgan’s Investment Banking Division in New York, where he played a leading role in numerous capital market and mergers and acquisitions transactions. In this capacity, he advised senior management and boards of directors of J.P. Morgan's key U.S. clients, including several S&P 500 healthcare firms. Prior to joining J.P. Morgan, Tomer worked in Citigroup's Investment Bank in New York. From 2000 to 2003, he served as an economist in the Financial Advisory Unit to the Chief of Staff of the Israel Defense Forces. Tomer holds a Ph.D. in Finance and Economics (with Distinction) from Columbia Business School and has published a number of corporate finance articles in leading academic and practitioner journals. He also holds an M.Sc. in Finance and Accounting (Magna Cum Laude) and a B.A. in Economics and Management (Magna Cum Laude), both from Tel-Aviv University. https://www.linkedin.com/in/tomerberkovitz/ | https://www.amoon.fund/ Get in touch: www.jamessomauroo.com | www.somx.co.uk

Amit Patel is the founder of a brand new digital health insuretech startup, called hlthie. Previously, he was an intrapreneur responsible for incubating, testing and scaling innovative and compelling customer propositions as director of vew ventures at bupa. He is a start-up advisor and a tech enthusiast with keen interest in exponential technologies (e.g. Blockchain / DLT, ML / AI etc) and their application in healthcare and insurance. Previously, Amit has held several Senior Roles at Bupa including Strategy & M&A Director for Bupa UK. Prior to Bupa, he worked as a Strategy Consultant at LEK – a top tier Strategy Consulting firm - advising Fortune 500 companies and private equity investors on growth strategy and M&A. Amit started his career in Medicine and trained as a General Surgeon working in the NHS. https://www.linkedin.com/in/amitpatel911/ Get in touch: www.jamessomauroo.com | www.somx.co.uk

This week's Sunday Session is on grant funding and James explains Innovate UK and SBRI funding for the UK and Europe. He talks about a couple of different grants out currently, how to apply and what they're looking for. Check the grants out here: 1. Innovate UK: Biomedical Catalyst 2020 - https://apply-for-innovation-funding.service.gov.uk/competition/623/overview#summary 2. SBRI: Competition 17: Urgent and Emergency Care - https://sbrihealthcare.co.uk/wp-content/uploads/2020/07/SBRI-Healthcare-Competition-17-Challenge-Brief.pdf Get in touch: www.jamessomauroo.com | www.somx.co.uk

Dr Owain Rhys Hughes is the founder and CEO of Cinapsis. He has over 13 years of experience working as a doctor and he is a Fellow of the Royal College of Surgeons. He has been awarded a personal Fellowship from the Medical Research Council and has twice received the British Journal of Surgery Prize. Cinapsis SmartReferrals reduces A&E attendances by 83% and face-to-face appointments by 70% through advice & guidance. GPs can contact specialists for advice quickly and securely. Cinapsis SmartReferrals makes it very easy for primary care physicians, nurses, paramedics and pharmacists to talk directly and securely with local specialists. Specialists direct patient flow and improve efficiency by controlling when and where they see patients. Cinapsis SmartReferrals has been designed with consultants to help them work efficiently and without disruption. https://www.linkedin.com/in/owainrhyshughes/ | https://www.cinapsis.org/ Get in touch: www.jamessomauroo.com | www.somx.co.uk

James has read the reports from the McKinsey Global Institute and Octopus Ventures so you don't have to... but they're also linked below. McKinsey's "Prioritizing health: A prescription for prosperity" concludes that by improving health globally, we can save lives and inject trillions into the global economy and they lay out some key findings in the exec summary which gives you the best overview. And Octopus Ventures have pinpointed huge innovation opportunities in fertility treatment, with global investment over the last five-year period topping $2.2bn (rising to $750m last year). Check out the reports here: 1. https://www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/prioritizing-health-a-prescription-for-prosperity 2. https://octopusgroup.com/newsroom/latest-news/octopus-ventures-pinpoints-innovation-opportunities-in-fertility/ Get in touch: www.jamessomauroo.com | www.somx.co.uk

Charles is a scientist with interests at the intersection of physics, machine learning, and computational biology and is the founder of Unlearn.ai . Previously, Charles worked as a machine learning engineer at Leap Motion and a computational biologist at Pfizer. He was a Philippe Meyer Fellow in theoretical physics at École Normale Supérieure in Paris, France, and a postdoctoral scientist in biophysics at Boston University. Charles holds a Ph.D. in biophysics from Harvard University and a B.S. in biophysics from the University of Michigan. Unlearn creates Digital Twins to populate Intelligent Control Arms in clinical studies. While others leverage existing data, Unlearn generates a new type of data, for any type of patient. A Digital Twin is a longitudinal, computationally generated clinical record that describes what would have happened if a specific patient received a placebo. https://www.linkedin.com/in/drckf/ | www.unlearn.ai Get in touch: www.jamessomauroo.com | www.somx.co.uk